Palatin Technologies Inc PTN
$7.70
▼ -1.41%
($-0.11)
🎈 Low Float
🗓️ Earnings Next Week
Open
$8.20
Prev Close
$7.81
Day Range
$7.58 – $8.20
52W Range
$5.00 – $31.00
Market Cap
$13.70M
Beta
0.64
EPS (TTM)
$-1.69
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 1999-12-21 |
| Shares Out. | 1,780,000 |
| Website | palatin.com/ ↗ |
| Phone | 16094952200 |
| Employees | 29 |
| Revenue | $3.9M |
| Gross Profit | $3.9M |
| Net Income | -$1.4M |
| Free Cash Flow | -$15.0M |
| Total Assets | $13.2M |
| Total Liabilities | $2.6M |
| Equity | $10.6M |
About Palatin Technologies Inc
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Palatin Technologies Inc is a publicly traded company under the ticker symbol PTN on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)